Skip to Content

Vascular Manifestations of Systemic Autoimmune Diseases

Best Seller!

Edited by Ronald A. Asherson, Ricard Cervera, Douglas A. Triplett, Steven B. Abramson

Contributors: Yehuda Shoenfeld, Josep Font, Carol M. Black, Nicoletta Del Papa, R.H.W.M. Derksen, Michelle Petri, Sozos Loizou, Jean-Charles Piette, Kevin Davies, Jill J.F. Belch, P. J. Willems, Chris Denton, Anne Gompel, Michael Samarkos, Charles D. Pusey, Terence Cook, Xavier Bosch, Camille Frances, Babette Weksler, Robert Roubey, Ronit Simantov, Outi Vaarala, Pier Luigi Meroni, David D'Cruz, H. Michael Belmont, Jan Wilhelm Coh Tervaert, Miri Blank, Joan Merrill, Paul Bacon, Maria C. Cid, Fujio Numano, Ann Parke, Olcay Aydintug, Gale McCarty, Thomas Lehman, George Cromona, Scott Goodnight, Joan-Carles Reverter, Kevin Burnand, Marco Cerinic, Tim W. Higenbottam, Marco Matucci-Cerinic, Sergio Generini, Pan Sheng Fan, M. Bashar Kahaleh, Elena Raschi, Mario Garcia-Carrasco, Manuel Ramos-Casals, Cees GM Kallenberg, Ilan Krause, Robert Lahita, Karim Raza, David Carruthers, Jose Hernandez-Rodrigez, Josep M. Grau, Miguel Ingelmo, S. P. Wharton, Dolors Tassies, Gerard Espinosa, Matthew Waltham

Published January 25th 2001 by CRC Press – 624 pages

Purchasing Options:

Description

Not too long ago, it was thought that inflammation of blood vessels was the sole manifestation of systemic autoimmune diseases. Today, however, we know that disorders of coagulation, injuries to both neutrophils and endothelial cells, and certain lipids and amino acids are all intricately involved in the development of vascular disease. How are all these processes linked? What strategies can we employ or develop to halt the progression of vascular damage? What are the best ways to control acute vasculitis and vasospasm therapeutically? What are the risks and benefits of various strategies for the prevention of clotting? How soon should we initiate preventive strategies that protect blood vessels from arteriosclerosis in people with acute rheumatic diseases? What should be the nature of those strategies?

Vascular Manifestations of Systemic Autoimmune Diseases provides answers to all these questions. Ronald Asherson, Richard Cervera,Steven B. Abramson, Jean-Charles Piette, and Douglas Triplett- all international experts in the field-have assembled a collection of works that provide a comprehensive analysis of vascular irregularities. Now that most individuals survive the onset of acute systemic autoimmune diseases and live for decades more, halting the long-term attack on vasculature is increasingly important.

Vascular Manifestations of Systemic Autoimmune Diseases not only describes the clinical symptoms of vascular diseases; it also covers in one volume the many mechanisms involved in the pathogenesis of these disorders and addresses the newest treatments available for them.

Reviews

"This book integrates the current understanding in the field of the biology underlying these varied vasculitic syndromes with their clinical presentations and the therapeutic strategies used to treat them."

- Deborah Jane Lenschow, MD, PhD, Washington University School of Medicine, Doody's Notes

Contents

Section I: Mechanisms of Vascular Disease

Pathology of Vascular Disease, H. Terence Cook and Charles D. Pusey

Coagulation Abnormalities, Douglas A. Triplett

Antiphospholipid Antibodies, Robert A. S. Roubey

Platelet Disorders in Autoimmune Diseases

Ronit Simantov and Babette B. Weksler

Immunology of Atherosclerosis, Outi Vaarala

Homocysteine and Vascular Disease in the

Autoimmune Connective Tissue Diseases,

Michelle Petri

Vascular Tone Control and Raynaud´s Phenomenon,

Marco Matucci-Cerinic, Sergio Generini, Pan Sheng Fan,and M. Bashar Kahaleh

Antineutrophil Cytoplasmic Antibodies,

Xavier Bosch and Josep Font

Antiendothelial Cell Antibodies, Pier Luigi Moroni, Nicoletta del Papa, Elena Raschi

Cryoglobulins, Mario García-Carrasco, Manel Ramos-Casals, Ricard Cervera, and Josep Font

Markers of Endothelial Damage, David P. D'Cruz

Systemic Inflammatory Response Syndrome,

Systemic Lupus Erythematosus, and

Thrombosis, H. Michael Belmont and Steven B.

Abramson

Leukocyte Cell Adhesion Molecules in Vasculitis,

Jan Willem Cohen Tervaert, and Cees G. M. Kallenberg

Experimental Induction of Vascular Disease

Ilan Krause, Miri Blank, Yehuda Shoenfeld

Hormones and Vascular Disease, Joan T. Merrill and Robert G. Lahita

Section II: Clinical Manifestations

Vascular Manifestations in Necrotizing and

Granulomatous Vasculitides, Karim Raza, David

M. Carruthers, Paul A. Bacon

Vascular Manifestations in Giant-Cell Arteritis,

María C. Cid, José Hernández-Rodríguez, Josep M. Grau

Vascular Manifestations in Takayasu Arteritis, Fujio Numano

Vascular Manifestations in Systemic Lupus Erythematosus, Josep Font, Ricard Cervera, Miguel Ingelmo

Vascular Manifestations in the Antiphospholipid Syndrome, Ronald A. Asherson and Ricard Cervera

Vascular Manifestations in Sjögren´s Syndrome, Anne Parke

Vascular Manifestations of Progressive Systemic Sclerosis, Christopher P. Denton and Carol M. Black

Vascular Manifestations in Rheumatoid Arthritis,

Dermato/Polymyositis, and Mixed Connective

Tissue Disease, Jean-Charles Piette and Camille

Francès

Vascular Manifestations in Relapsing Polychondritis,

Jean-Charles Piette, Philippe Vinceneux, Camille Francès

Vascular Manifestations of Behçet´s Disease, Olcay Aydintug

Vascular Manifestations in Microangiopathic Syndromes, Gale A. McCarty

The Vasculitic Diseases of Childhood, Thomas J. A. Lehman

Pulmonary Hypertension, S.P. Wharton and T.W. Higenbottam

Renal Vasculitis, Michael Samarkos, Sozos Loizou, Kevin A. Davies

Skin Manifestations of Vasculitis,

Camille Francès, Pierre-André Bécherel, Jean-Charles Piette

Section III: Treatment

Pharmacological Treatments for Thrombotic Diseases,

Joan-Carles Reverter, Dolors Tàssies, Gerard Espinosa

Hormone Replacement Therapy for "At Risk"

Patients with Connective Tissue Diseases, Ann

Gompel

Surgical Treatments, Matthew Waltham and Kevin G. Burnand

Therapy of Systemic Vasculitis, David M. Carruthers, Karim Raza, Paul A. Bacon

Anticoagulation Therapy for the Antiphospholipid Syndrome, Scott Goodnight

The Treatment of Raynaud´s Phenomenon, Marco Martucci Cerinic, Sergio Generini, James R. Seibold

Treatment of Pulmonary Hypertension, S.P. Wharton and T.W. Higenbottam

Related Subjects

  1. Rheumatology
  2. Immunology

Name: Vascular Manifestations of Systemic Autoimmune Diseases (Hardback) – CRC Press 
Description: Edited by Ronald A. Asherson, Ricard Cervera, Douglas A. Triplett, Steven B. AbramsonContributors: Yehuda Shoenfeld, Josep Font, Carol M. Black, Nicoletta Del Papa, R.H.W.M. Derksen, Michelle Petri, Sozos Loizou, Jean-Charles Piette, Kevin Davies, Jill J.F. Belch, P. J. Willems, Chris Denton, Anne Gompel, Michael Samarkos, Charles D. Pusey, Terence Cook, Xavier Bosch, Camille Frances, Babette Weksler, Robert Roubey, Ronit Simantov, Outi Vaarala, Pier Luigi Meroni, David D'Cruz, H. Michael Belmont, Jan Wilhelm Coh Tervaert, Miri Blank, Joan Merrill, Paul Bacon, Maria C. Cid, Fujio Numano, Ann Parke, Olcay Aydintug, Gale McCarty, Thomas Lehman, George Cromona, Scott Goodnight, Joan-Carles Reverter, Kevin Burnand, Marco Cerinic, Tim W. Higenbottam, Marco Matucci-Cerinic, Sergio Generini, Pan Sheng Fan, M. Bashar Kahaleh, Elena Raschi, Mario Garcia-Carrasco, Manuel Ramos-Casals, Cees GM Kallenberg, Ilan Krause, Robert Lahita, Karim Raza, David Carruthers, Jose Hernandez-Rodrigez, Josep M. Grau, Miguel Ingelmo, S. P. Wharton, Dolors Tassies, Gerard Espinosa, Matthew Waltham. Not too long ago, it was thought that inflammation of blood vessels was the sole manifestation of systemic autoimmune diseases. Today, however, we know that disorders of coagulation, injuries to both neutrophils and endothelial cells, and certain lipids...
Categories: Rheumatology, Immunology